Gastroenterology & Hepatology Focused Research

Specialized gastroenterology and hepatology expertise to support clinical trials and real-world evidence programs covering a wide range of digestive and liver disorders.

Supporting Clinical Research in Gastroenterology & Hepatology

Digestive and liver diseases affect millions worldwide – driven by diets, environmental exposures, genetics, and rising stress levels. With a significant portion of the global population suffering from functional gastrointestinal disorders or metabolic liver diseases like MASLD/MASH, the need for effective, innovative treatments has never been greater. Omega Research provides comprehensive support for Phase II-IV gastroenterology and hepatology trials and robust observational studies. As a strategic partner with a proven track record, we deliver the scientific insight, operational excellence, and flexibility needed to navigate the complexities of each study and accelerate progress for patients.

GI & Hepatology CRO Expertise

Omega Research brings deep, global experience across a broad spectrum of gastrointestinal and liver diseases – from common to complex and rare indications. Our in-house medical leadership and therapeutically aligned operational teams bring proven expertise that drives high-quality execution and accelerates timelines. We’ve supported successful trials and RWE studies across key GI and hepatology indications, including

  • Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease
  • Esophageal and gastric disorders, including GERD, NERD, eosinophilic esophagitis, and gastroparesis
  • Functional gastrointestinal disorders, including irritable bowel syndrome (IBS), functional constipation, and functional diarrhea
  • Metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD), including MASH-related cirrhosis
  • Alcoholic hepatitis and rare liver diseases
  • Hepatitis B & C and other viral liver diseases

Collaborative & Cross-Functional Teams to Execute Your GI & Hepatology Study

At Omega Research, collaboration is at the core of our success in GI and hepatology clinical research. Our integrated teams – spanning medical, regulatory, and operational experts – work seamlessly to provide strategic oversight and execution at every stage of development.

Our key capabilities include:

  • Comprehensive Site Selection & Management: Leveraging our global network of specialized GI and hepatology sites
  • Centralized Imaging & Histopathology Coordination: Expert management of endoscopy, histology, and radiology core labs
  • Advanced Laboratory Support: Specialized handling of biomarkers and novel laboratory endpoints
  • Patient Recruitment Strategies: Tailored approaches for challenging GI and liver disease populations
  • Real-World Evidence Generation: Post-marketing studies and treatment pattern analysis

Collaborative & Cross-Functional Teams to Execute Your GI & Hepatology Study

At Omega Research, collaboration is at the core of our success in GI and hepatology clinical research. Our integrated teams – spanning medical, regulatory, and operational experts – work seamlessly to provide strategic oversight and execution at every stage of development.

Our key capabilities include:

Comprehensive Site Selection & Management: Leveraging our global network of specialized GI and hepatology sites

Centralized Imaging & Histopathology Coordination: Expert management of endoscopy, histology, and radiology core labs

Advanced Laboratory Support: Specialized handling of biomarkers and novel laboratory endpoints

Patient Recruitment Strategies: Tailored approaches for challenging GI and liver disease populations

Real-World Evidence Generation: Post-marketing studies and treatment pattern analysis

Comprehensive IBD Clinical Trial Support

Omega Research offers deep therapeutic expertise and global operational experience in managing clinical trials for inflammatory bowel disease (IBD). We understand the unique challenges of IBD trials, including recruitment and retention and the critical need for centralized endoscopy and histopathology review. Our understanding of these complex conditions helps us position our Sponsors for success.

MASH/MASLD Clinical Research Expertise

With the growing pandemic of metabolic liver diseases, Omega Research has developed specialized capabilities in MASH/MASLD research. Our experience includes:

  • Clinical trial design for metabolic liver diseases
  • Coordination of advanced imaging endpoints (MRI-PDFF, MR elastography)
  • Management of complex biomarker panels
  • Long-term outcomes research

Why Choose Omega Research for GI & Hepatology Studies?

  • Therapeutic Depth: Direct access to GI and hepatology medical experts
  • Operational Excellence: Proven track record in complex GI clinical trials
  • Global Reach with Local Expertise: Strategic presence across key markets
  • Integrated Solutions: From early-phase trials to post-marketing studies
  • Quality Assurance: Rigorous quality management systems

QUOTE

The field of gastroenterology and hepatology is rapidly evolving with new therapeutic approaches and diagnostic technologies. Our team at Omega Research is committed to advancing this field through rigorous clinical research and meaningful real-world evidence generation.